Information

BioMotiv is a therapeutic accelerator focused on developing a portfolio of novel medicines. By partnering with leading scientists and institutions, BioMotiv aims to bring breakthrough discoveries to market. The accelerator provides a comprehensive suite of support services to its portfolio companies, including strategic guidance, operational support, and access to capital. Entrepreneurs benefit from BioMotiv's extensive network of industry experts and investors, which can accelerate the development and commercialization of their innovative therapies.

How to Apply

To apply for the BioMotiv accelerator, interested parties should visit the official website and navigate to the 'Contact' or 'Apply' section. There, they can find detailed instructions on the application process, including submission requirements and deadlines. Applicants typically need to provide information about their scientific research, business plan, and team. It is recommended to have a well-prepared pitch deck and supporting documents to enhance the chances of selection.

Total number of startups invested: 6

Average Funding: BioMotiv typically invests in early-stage therapeutic ventures, with funding rounds varying based on the specific needs and potential of each company. Exact figures are not publicly disclosed.

Industry: Biotechnology, Therapeutics, Pharmaceuticals

Market: United States